SPONSOR
Second Affiliated Hospital of Guangzhou Medical University
Total Trials
7
Recruiting
7
Phases
Phase 1, Phase 2, Phase 3
Conditions studied: Pancreas CancerLung CancerLiver CancerMesotheliomaCAR-T Cell TherapySolid Tumor, AdultHepatocellular CarcinomaHepatocellular Carcinoma Non-resectableSurgeryNon-small Cell Lung Cancer
Second Affiliated Hospital of Guangzhou Medical University is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Pancreas Cancer, Lung Cancer, Liver Cancer, Mesothelioma.
The trial portfolio spans Phase 1, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Second Affiliated Hospital of Guangzhou Medical University
How many clinical trials has Second Affiliated Hospital of Guangzhou Medical University sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Second Affiliated Hospital of Guangzhou Medical University, of which 7 are actively recruiting participants. These trials cover conditions including Pancreas Cancer, Lung Cancer, Liver Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Second Affiliated Hospital of Guangzhou Medical University research focus on?
Second Affiliated Hospital of Guangzhou Medical University clinical trials span Pancreas Cancer, Lung Cancer, Liver Cancer, Mesothelioma, CAR-T Cell Therapy, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Second Affiliated Hospital of Guangzhou Medical University clinical trial?
To participate in a Second Affiliated Hospital of Guangzhou Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Second Affiliated Hospital of Guangzhou Medical University trials with current recruitment status updated daily.
Clinical Trials by Second Affiliated Hospital of Guangzhou Medical University
NCT06196294 Phase 1
Recruiting
GPC3/Mesothelin-CAR-γδT Cells Against Cancers
Pancreas Cancer
NCT04770207 Phase 2
Recruiting
Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs
Hepatocellular Carcinoma
NCT05608200 Phase 3
Recruiting
Lenvatinib+Sintilimab+TACE vs. Lenvatinib+TACE for Advanced HCC
Hepatocellular Carcinoma Non-resectable
NCT06492421 Phase 2
Recruiting
Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.
Lung Cancer
NCT06492408 Phase 2
Recruiting
Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma.
Hepatic Cancer
NCT03949231 Phase 3
Recruiting
Infusion of PD1/PDL1/CTLA4 Inhibitors Via Hepatic Arterial for Immunotherapy of Hepatocellular Carcinoma
Liver Cancer
NCT04952272 Phase 1
Recruiting
Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors
Lung Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology